The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Progression from ductal carcinoma in situ to invasive breast cancer: Revisited
Open accessAbstract
Ductal carcinoma in situ (DCIS) is an intraductal neoplastic proliferation of epithelial cells that is separated from the breast stroma by an intact layer of basement membrane and myoepithelial cells. DCIS is a non‐obligate precursor of invasive breast cancer, and up to 40% of these lesions progress to invasive disease if untreated. Currently, it is not possible to predict accurately which DCIS would be more likely to progress to invasive breast cancer as neither the significant drivers of the invasive transition have been identified, nor has the clinical utility of tests predicting the likelihood of progression been demonstrated. Although molecular studies have shown that qualitatively, synchronous DCIS and invasive breast cancers are remarkably similar, there is burgeoning evidence to demonstrate that intra‐tumor genetic heterogeneity is observed in a subset of DCIS, and that the process of progression to invasive disease may constitute an ‘evolutionary bottleneck’, resulting in the selection of subsets of tumor cells with specific genetic and/or epigenetic aberrations. Here we review the clinical challenge posed by DCIS, the contribution of the microenvironment and genetic aberrations to the progression from in situ to invasive breast cancer, the emerging evidence of the impact of intra‐tumor genetic heterogeneity on this process, and strategies to combat this heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Self-citationAbsolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
Debnath, J., Muthuswamy, S. K., & Brugge, J. S. (2003) · Methods · doi:10.1016/s1046-2023(03)00032-x · Cited by 1,995
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967
The Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Reconstruction of functionally normal and malignant human breast tissues in mice
Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J. W., Carey, L., Richardson, A., & Weinberg, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401064101 · Cited by 804
Gene expression profiling of the tumor microenvironment during breast cancer progression
Ma, X.-J., Dahiya, S., Richardson, E., Erlander, M., & Sgroi, D. C. (2009) · Breast Cancer Research · doi:10.1186/bcr2222 · Cited by 629
Intraductal carcinoma of the breast: Follow-up after biopsy only
Page, D. L., Dupont, W. D., Rogers, L. W., & Landenberger, M. (1982) · Cancer · doi:10.1002/1097-0142(19820215)49:4<751::aid-cncr2820490426>3.0.co;2-y · Cited by 608
Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
Virnig, B. A., Tuttle, T. M., Shamliyan, T., & Kane, R. L. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp482 · Cited by 608
Inferring tumor progression from genomic heterogeneity
Navin, N., Krasnitz, A., Rodgers, L., Cook, K., Meth, J., Kendall, J., Riggs, M., Eberling, Y., Troge, J., Grubor, V., et al. (2010) · Genome Research · doi:10.1101/gr.099622.109 · Cited by 524
Self-citationDistinct epigenetic changes in the stromal cells of breast cancers
Hu, M., Yao, J., Cai, L., Bachman, K. E., van den Brûle, F., Velculescu, V., & Polyak, K. (2005) · Nature Genetics · doi:10.1038/ng1596 · Cited by 520
Solin, L. J., Gray, R., Baehner, F. L., Butler, S. M., Hughes, L. L., Yoshizawa, C., Cherbavaz, D. B., Shak, S., Page, D. L., Sledge, G. W., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt067 · Cited by 518
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
Intratumor Heterogeneity: Seeing the Wood for the Trees
Yap, T. A., Gerlinger, M., Futreal, P. A., Pusztai, L., & Swanton, C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003854 · Cited by 490
Sanders, M. E., Schuyler, P. A., Dupont, W. D., & Page, D. L. (2005) · Cancer · doi:10.1002/cncr.21069 · Cited by 485
Genetic heterogeneity and cancer drug resistance
Turner, N. C., & Reis-Filho, J. S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70335-7 · Cited by 454
Self-citationThe microenvironment in breast cancer progression: biology and implications for treatment
Place, A. E., Jin Huh, S., & Polyak, K. (2011) · Breast Cancer Research · doi:10.1186/bcr2912 · Cited by 413
Lyons, T. R., O'Brien, J., Borges, V. F., Conklin, M. W., Keely, P. J., Eliceiri, K. W., Marusyk, A., Tan, A.-C., & Schedin, P. (2011) · Nature Medicine · doi:10.1038/nm.2416 · Cited by 380
Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition
McDonald, O. G., Wu, H., Timp, W., Doi, A., & Feinberg, A. P. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2084 · Cited by 379
Breast cancer precursors revisited: molecular features and progression pathways
Lopez‐Garcia, M. A., Geyer, F. C., Lacroix‐Triki, M., Marchió, C., & Reis‐Filho, J. S. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03568.x · Cited by 347
Self-citationComparison of molecular phenotypes of ductal carcinoma in situand invasive breast cancer
Tamimi, R. M., Baer, H. J., Marotti, J., Galan, M., Galaburda, L., Fu, Y., Deitz, A. C., Connolly, J. L., Schnitt, S. J., Colditz, G. A., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2128 · Cited by 343
MCF10DCIS.com Xenograft Model of Human Comedo Ductal Carcinoma In Situ
Miller, F. R., Santner, S. J., Tait, L., & Dawson, P. J. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1185a · Cited by 342
Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.697 · Cited by 340
Buerger, H., Otterbach, F., Simon, R., Poremba, C., Diallo, R., Decker, T., Riethdorf, L., Brinkschmidt, C., Dockhorn-Dworniczak, B., & Boecker, W. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199903)187:4<396::aid-path286>3.0.co;2-l · Cited by 328
Qiu, W., Hu, M., Sridhar, A., Opeskin, K., Fox, S., Shipitsin, M., Trivett, M., Thompson, E. R., Ramakrishna, M., Gorringe, K. L., et al. (2008) · Nature Genetics · doi:10.1038/ng.117 · Cited by 282
Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and Neoplasia
Gudjonsson, T., Adriance, M. C., Sternlicht, M. D., Petersen, O. W., & Bissell, M. J. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-9586-4 · Cited by 281
Abdel-Fatah, T. M. A., Powe, D. G., Hodi, Z., Lee, A. H. S., Reis-Filho, J. S., & Ellis, I. O. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213368.41251.b9 · Cited by 271
Self-citationAn intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
Behbod, F., Kittrell, F. S., LaMarca, H., Edwards, D., Kerbawy, S., Heestand, J. C., Young, E., Mukhopadhyay, P., Yeh, H.-W., Allred, D. C., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2358 · Cited by 268
Molecular markers in ductal carcinoma in situ of the breast.
PORTER, D. A., Lahti‐Domenici, J., Keshaviah, A. P., Bae, Y. K., Argani, P., Marks, J. R., Richardson, A. L., Cooper, A. G., Strausberg, R. L., Riggins, G. J., et al. (2003) · PubMed · Cited by 265
LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
Barker, H. E., Chang, J., Cox, T. R., Lang, G., Bird, D., Nicolau, M., Evans, H. R., Gartland, A., & Erler, J. T. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2868 · Cited by 252
The human myoepithelial cell is a natural tumor suppressor.
Sternlicht, M. D., Kedeshian, P. A., Shao, Z. M., Safarians, S., & Barsky, S. H. (1997) · PubMed · Cited by 248
Molecular cytogenetic analysis of 11 new breast cancer cell lines
Forozan, F., Veldman, R., Ammerman, C. A., Parsa, N. Z., Kallioniemi, A., Kallioniemi, O.-P., & Ethier, S. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6695007 · Cited by 219
Bryan, B. B., Schnitt, S. J., & Collins, L. C. (2006) · Modern Pathology · doi:10.1038/modpathol.3800570 · Cited by 217
Identification of a basal-like subtype of breast ductal carcinoma in situ
Livasy, C. A., Perou, C. M., Karaca, G., Cowan, D. W., Maia, D., Jackson, S., Tse, C.-K., Nyante, S., & Millikan, R. C. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.08.017 · Cited by 215
Hu, M., Peluffo, G., Chen, H., Gelman, R., Schnitt, S., & Polyak, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813306106 · Cited by 205
Do Myoepithelial Cells Hold the Key for Breast Tumor Progression?
Polyak, K., & Hu, M. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-9584-6 · Cited by 180
Yao, J., Weremowicz, S., Feng, B., Gentleman, R. C., Marks, J. R., Gelman, R., Brennan, C., & Polyak, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4083 · Cited by 179
Tumor progression in four mammary epithelial cell lines derived from the same patient.
Band, V., Zajchowski, D. A., Swisshelm, K. L., Trask, D. K., Kulesa, V., Cohen, C., Connolly, J. L., & Sager, R. (1990) · PubMed · Cited by 176
Promoter CpG island hypermethylation during breast cancer progression
Park, S. Y., Kwon, H. J., Lee, H. E., Ryu, H. S., Kim, S., Kim, J. H., Kim, I. A., Jung, N., Cho, N., & Kang, G. H. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-1013-6 · Cited by 166
A Human Breast Cell Model of Preinvasive to Invasive Transition
Rizki, A., Weaver, V. M., Lee, S.-Y., Rozenberg, G. I., Chin, K., Myers, C. A., Bascom, J. L., Mott, J. D., Semeiks, J. R., Grate, L. R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2225 · Cited by 161
Sproul, D., Nestor, C., Culley, J., Dickson, J. H., Dixon, J. M., Harrison, D. J., Meehan, R. R., Sims, A. H., & Ramsahoye, B. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013224108 · Cited by 159
Vargas, A. C., Reed, A. E. M., Waddell, N., Lane, A., Reid, L., Smart, C. E., Cocciardi, S., Silva, L. M. D., Song, S., Chenevix‐Trench, G., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2123-4 · Cited by 159
Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Vincent‐Salomon, A., Lucchesi, C., Gruel, N., Raynal, V., Pierron, G., Goudefroye, R., Reyal, F., Radvanyi, F., Salmon, R. J., Thiery, J. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1465 · Cited by 159
Lee, S., Stewart, S., Nagtegaal, I., Luo, J., Wu, Y., Colditz, G., Medina, D., & Allred, D. C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0636 · Cited by 158
Hernández, L., Wilkerson, P. M., Lambros, M. B. K., Campion‐Flora, A., Rodrigues, D. N., Gauthier, A., Cabral, C., Pawar, V. S., Mackay, A. G., A’Hern, R., et al. (2012) · The Journal of Pathology · doi:10.1002/path.3990 · Cited by 153
Self-citationMolecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
Muggerud, A. A., Hallett, M. T., Johnsen, H., Sahlberg, K. K., Zhou, W., Tahmasebpoor, S., Amini, R., Botling, J., Børresen‐Dale, A., Sørlie, T., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.007 · Cited by 142
Moelans, C. B., Verschuur‐Maes, A. H. J., & van Diest, P. J. (2011) · The Journal of Pathology · doi:10.1002/path.2930 · Cited by 138
Myoepithelial Cells: Autocrine and Paracrine Suppressors of Breast Cancer Progression
Barsky, S. H., & Karlin, N. J. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-9585-5 · Cited by 132
Pathology of Invasive Breast Cancer
Bleiweiss, I. J. (2005) · Elsevier eBooks · doi:10.1016/b978-0-443-06634-4.50012-1 · Cited by 129
Aubele, M. M., Mattis, A. E., Zitzelsberger, H. F., Walch, A. K., Kremer, M., Hutzler, P., Höfler, H., & Werner, M. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00205-2 · Cited by 122
Park, K., Han, S., Kim, H. J., Kim, J., & Shin, E. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02403.x · Cited by 122
Heselmeyer‐Haddad, K., Berroa-Garcia, L., Bradley, A., Ortiz-Melendez, C., Lee, W.-J., Christensen, R., Prindiville, S. A., Calzone, K. A., Soballe, P. W., Hu, Y., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.07.012 · Cited by 118
Cancer genome-sequencing study design
Mwenifumbo, J. C., & Marra, M. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3445 · Cited by 104
Knudsen, E. S., Ertel, A., Davicioni, E., Kline, J., Schwartz, G. F., & Witkiewicz, A. K. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1894-3 · Cited by 98
Robanus-Maandag, E. C., Bosch, C. A. J., Kristel, P., Hart, A. A. M., Faneyte, I. F., Nederlof, P. M., Peterse, J. L., & van de Vijver, M. J. (2003) · The Journal of Pathology · doi:10.1002/path.1385 · Cited by 93
Imbalzano, K. M., Tatarkova, I., Imbalzano, A. N., & Nickerson, J. A. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-7 · Cited by 89
Steinman, S., Wang, J., Bourne, P. A., Yang, Q., & Tang, P. (2007) · PubMed · Cited by 82
Johnson, C. E., Gorringe, K. L., Thompson, E. R., Opeskin, K., Boyle, S. E., Wang, Y.-K., Hill, P., Mann, G. B., & Campbell, I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1835-1 · Cited by 78
Gene amplification in ductal carcinoma in situ of the breast
Burkhardt, L., Grob, T. J., Hermann, I., Burandt, E., Choschzick, M., Jänicke, F., Müller, V., Bokemeyer, C., Simon, R., Sauter, G., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0675-8 · Cited by 71
Mechanisms of Disease: breast tumor pathogenesis and the role of the myoepithelial cell
Barsky, S. H., & Karlin, N. J. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0450 · Cited by 62
Gao, Y., Niu, Y., Wang, X., Wei, L., & Lu, S. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0408-1 · Cited by 54
Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer
Verschuur‐Maes, A. H. J., de Bruin, P. C., & van Diest, P. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2301-4 · Cited by 49
[Carcinoma in situ of the female breast].
Wunderlich, M., & Bergner, R. (1974) · PubMed · Cited by 38
Souter, L., Andrews, J. D., Zhang, G., Cook, A. C., Postenka, C. O., Al‐Katib, W., Leong, H. S., Rodenhiser, D. I., Chambers, A. F., & Tuck, A. B. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.97 · Cited by 33
Ottesen, G. L. (2003) · PubMed · Cited by 33
Johnson, C., Gorringe, K. L., Er, T., Opeskin, K., Boyle, S., Wang, Y., Hill, P., Mann, G. B., & Campbell, I. (2012) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-10-s2-a93 · Cited by 26
Giardina, C., Serio, G., Lepore, G., et al. (2003) · PubMed · Cited by 14
Cited by
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing
Casasent, A. K., Schalck, A., Gao, R., Sei, E., Long, A., Pangburn, W., Casasent, T., Meric-Bernstam, F., Edgerton, M. E., & Navin, N. E. (2018) · Cell · doi:10.1016/j.cell.2017.12.007 · Cited by 411
Ductal carcinoma in situ: to treat or not to treat, that is the question
on behalf of the PRECISION team, van Seijen, M., Lips, E. H., Thompson, A. M., Nik-Zainal, S., Futreal, A., Hwang, E. S., Verschuur, E., Lane, J., Jonkers, J., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0478-6 · Cited by 320
Family history and risk of breast cancer: an analysis accounting for family structure
Brewer, H. R., Jones, M. E., Schoemaker, M. J., Ashworth, A., & Swerdlow, A. J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4325-2 · Cited by 316
Impact of Epithelial–Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
Strell, C., Paulsson, J., Jin, S.-B., Tobin, N. P., Mezheyeuski, A., Roswall, P., Mutgan, C., Mitsios, N., Johansson, H., Wickberg, S. M., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy234 · Cited by 158
Metadata
- Authors
- Cowell, C. F., Weigelt, B., Sakr, R. A., Ng, C. K. Y., Hicks, J., King, T. A., & Reis-Filho, J. S.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2013-07-12
- Volume
- 7
- Issue
- 5
- Pages
- 859-869
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W1966934872
- Cited by
- 257
- References
- 76
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.